A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma

Martin H. Voss, Rupal S. Bhatt, Nicholas J. Vogelzang, Mayer Fishman, Robert S. Alter, Brian I. Rini, J. Thaddeus Beck, Monika Joshi, Ralph Hauke, Michael B. Atkins, Earle Burgess, Theodore F. Logan, David Shaffer, Rahul Parikh, Nauman Moazzam, Xiaosha Zhang, Chad Glasser, Matthew L. Sherman, Elizabeth R. Plimack

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 2, randomized trial evaluating the combination of dalantercept plus axitinib in patients with advanced clear cell renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences